United Kingdom / China / Japan / Canada / Australia / India / United States / Ireland / /
Currency
USD / GBP / / /
Event
FDA Phase / Second Stock Issuance / Business Partnership / M&A / Company Listing Change / Product Recall / Reorganization / Product Issues / Employment Change / /
Facility
Stanford University / University of Queensland / Dr Chiplin’s Pharmacy / University of London / Hope Cancer Centre / Wollongong University / Queensland University of Technology / University of New South Wales / College Hill / University of Massachusetts / University of Nottingham / Children’s Cancer Institute / /
IndustryTerm
human therapy applications / technology industries / media strategy / healthcare industry / treatment for HIV / expressed technology / therapy for the orphan genetic eye disease / clinical applications / therapies for the treatment of life threatening diseases / biotechnology / industry / gene therapy product / ddRNAi technology / therapeutics for intractable diseases / pain product / therapy for a human orphan genetic disease / gene silencing technology / large pharmaceutical / finance / investment banking / ddRNAi product / therapies for Hepatitis C / manufacturing / technology lawyers / pharmaceutical / transformational technology / treatment for an orphan disease / therapeutic products / therapy for HIV / /
MedicalCondition
non-small cell lung cancer / Retinitis Pigmentosa - Genable / TTR-mediated amyloidosis / orphan disease / different diseases / amyloidosis / diseases / human non-small cell lung tumours / chronic pain / rare genetic diseases / Hepatitis C / chronic and lifethreatening conditions / rare untreatable disease / intractable diseases / human orphan genetic disease / common cancer / disease / Advanced Cancer / pain / Lung cancer / neurological diseases / Chemotherapy-resistant lung cancer / viral infection / HBV / Retinitis pigmentosa / OPMD orphan disease / rheumatoid arthritis / hepatitis B / drug resistant lung cancer / lipoprotein lipase deficiency / Phase I/II clinical trial cancer / cancer / Chronic / HCV / AIDS / Oculopharyngeal Muscular Dystrophy / high profile diseases / AIDS-related lymphoma patients / terminal cancer / orphan genetic eye disease Retinitis Pigmentosa / autoimmune diseases / cancers / HBV infection / These diseases / rare disease / infectious diseases / eye disease / /
College Hill / Benitec Biopharma YouTube channel / Share Registry Computershare Investor Services Pty Limited Yarra Falls / /
OperatingSystem
Genera / /
Organization
Queensland University / Institut de Myologie / Children’s Cancer Institute Australia / Council of Royal Holloway / University of Queensland / United Kingdom Intellectual Property Office / FDA / University of London / University of Massachusetts / Queensland University of Technology / Brisbane / Carnegie Institution / Wollongong University / Japanese Patent Office / CBO and CIG / European Medicines Authority / Hope Cancer Centre / University of New South Wales / Congress / British Patent Office / European Medicines Agency / University of Nottingham / Stanford University / CIG / /
Person
Peter Francis / Capucine Trollet / John Chiplin / Peter French Registered / George Dickson / Peter French / David Suhy (Tacere) / Mel Bridges / Greg West / Maria Kavallaris / David Yeomans / York Zhu / Carl held / David Suhy / Ken Reed / Iain Ross / Carl Stubbings / Geoff Symonds / John Rossi / Michael Graham / / /
Position
Vice President / NonExecutive Director / Chief / Director Number / Chief Scientific Officer / CEO / Professor / Qualified Chartered Director / board member / Non-Executive Chairman / legal specialist / co-author / Chief Scientist / pain mediator / public company director / second driver / Non-Executive Director / Director and audit committee Chairman / Vice Chairman / Chief Executive Officer / general media strategy / Chartered Accountant / AUDITOR / head / Entrepreneur / Chief Business Officer / Director Appointed / Contents Corporate Directory CHAIRMAN AND THE CEO / experienced business man / FAICD Non-Executive Director / Company Secretary / Chairman / Director / /